0 items USD 0.00Search
- Did you mean
- crown diseases
Your search for "crohn diseases" gave back 77828 results.
Inflammatory bowel disease is a condition generally caused when immune system attacks harmless bacteria, virus, or food in the intestine. The most...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
MRRPB5
April 2024
Price: USD 2,900.00
Tysabri (natalizumab) is a monoclonal antibody used in to treat relapsing forms of multiple sclerosis. Tysabri is also used to treat moderate to...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
MRRPB5
September 2024
Price: USD 3,950.00
The global Smart Pill Technologies market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
GIR
June 2024
Price: USD 3,480.00
Tysabri (natalizumab) is a monoclonal antibody used in to treat relapsing forms of multiple sclerosis. Tysabri is also used to treat moderate to...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
MRRPB5
January 2024
Price: USD 2,900.00
The global market for Humira was valued at US$ 14370 million in the year 2024 and is projected to reach a revised size of US$ 7907 million by 2031,...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
MRRPB5
May 2025
Price: USD 2,900.00
Integrin Beta 7 - Pipeline Review, H2 2019 Summary Integrin Beta 7 (Gut Homing Receptor Beta Subunit or ITGB7) - Integrin beta-7 is an integrin...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
Global Â鶹Դ´s Direct
August 2019
Price: USD 3,500.00
Inflammatory bowel disease is a condition generally caused when immune system attacks harmless bacteria, virus, or food in the intestine. The most...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
MRRPB5
September 2024
Price: USD 3,950.00
Tysabri (natalizumab) is a monoclonal antibody used in to treat relapsing forms of multiple sclerosis. Tysabri is also used to treat moderate to...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
MRRPB5
September 2024
Price: USD 3,950.00
Tysabri (natalizumab) is a monoclonal antibody used in to treat relapsing forms of multiple sclerosis. Tysabri is also used to treat moderate to...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
MRRPB5
September 2024
Price: USD 3,950.00
Infliximab is a monoclonal anti tumor necrosis factor alpha antibody used in the treatment of a wide variety of inflammatory conditions such as...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
MRRPB5
November 2024
Price: USD 3,950.00
Inflammatory bowel disease (IBD) is a group of inflammatory conditions of the colon and small intestine. Crohn's diseaseand ulcerative colitis...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
MRRPB5
February 2023
Price: USD 2,900.00
Tysabri (natalizumab) is a monoclonal antibody used in to treat relapsing forms of multiple sclerosis. Tysabri is also used to treat moderate to...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
MRRPB5
January 2024
Price: USD 2,900.00
Tysabri (natalizumab) is a monoclonal antibody used in to treat relapsing forms of multiple sclerosis. Tysabri is also used to treat moderate to...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
MRRPB5
January 2024
Price: USD 2,900.00
Tysabri (natalizumab) is a monoclonal antibody used in to treat relapsing forms of multiple sclerosis. Tysabri is also used to treat moderate to...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
MRRPB5
January 2024
Price: USD 2,900.00
The global Infliximab and Biosimilar market size was valued at US$ million in 2023. With growing demand in downstream market, the Infliximab and...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
LPI
February 2024
Price: USD 3,660.00
Ìý
Filter By Report Date
Filter By Industry
Filter By Country
- Global (77450) Apply Global filter
- BRIC (2) Apply BRIC filter
- Asia (1) Apply Asia filter
- Caribbean (1) Apply Caribbean filter
- Emerging Â鶹Դ´s (1) Apply Emerging Â鶹Դ´s filter
- G8 (1) Apply G8 filter
- Korea (1) Apply Korea filter
- Latin America (1) Apply Latin America filter
- Oceania (1) Apply Oceania filter
